Bailard’s VanEck Biotech ETF BBH Stock Holding History

Bailard’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,635	Closed	-$265K	–	692
2022 Q1	$265K	Hold	1,635	–	–	0.01%	581
2021 Q4	$310K	Hold	1,635	–	–	0.01%	526
2021 Q3	$330K	Hold	1,635	–	–	0.01%	503
2021 Q2	$330K	Sell	1,635 -135	-8%	-$25.1K	0.01%	492
2021 Q1	$311K	Hold	1,770	–	–	0.01%	503
2020 Q4	$300K	Hold	1,770	–	–	0.01%	440
2020 Q3	$287K	Buy	1,770 +144	+9%	+$23.4K	0.01%	394
2020 Q2	$265K	Hold	1,626	–	–	0.01%	385
2020 Q1	$208K	Hold	1,626	–	–	0.01%	400
2019 Q4	$227K	Buy	+1,626	New	+$214K	0.01%	468
2019 Q3	–	Sell	-1,626	Closed	-$210K	–	533
2019 Q2	$210K	Buy	+1,626	New	+$200K	0.01%	487
2019 Q1	–	Sell	-2,097	Closed	-$233K	–	543
2018 Q4	$233K	Buy	2,097 +272	+15%	+$32.9K	0.02%	454
2018 Q3	$249K	Hold	1,825	–	–	0.01%	488
2018 Q2	$219K	Sell	1,825 -135	-7%	-$15.9K	0.01%	486
2018 Q1	$236K	Sell	1,960 -200	-9%	-$25.1K	0.02%	442
2017 Q4	$269K	Hold	2,160	–	–	0.02%	388
2017 Q3	$290K	Buy	2,160 +135	+7%	+$17.6K	0.02%	250
2017 Q2	$254K	Hold	2,025	–	–	0.02%	253
2017 Q1	$241K	Hold	2,025	–	–	0.02%	263
2016 Q4	$218K	Buy	+2,025	New	+$220K	0.02%	286

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bailard's BBH Position: Q2 2022 in Review

Bailard sold out of VanEck Biotech ETF (BBH) in Q2 2022, closing a stake of 1,635 shares — an estimated $265K sold.

Bailard first reported a position in BBH in Q4 2016 and held it in 20 quarters. The position peaked at $330K in Q3 2021. 108 funds tracked by Wall St. Rank hold BBH as of Q2 2022.

Bailard reported no remaining VanEck Biotech ETF position as of Q2 2022 after selling out during the quarter.
Bailard sold 1,635 VanEck Biotech ETF shares in Q2 2022, an estimated $265K.
Bailard first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 20 quarters.
Bailard's VanEck Biotech ETF position peaked at $330K in Q3 2021.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2022.

Based on Bailard's 13F filing for Q2 2022, filed 27 Jul 2022.